Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction
Levy B, Clere-Jehl R, Legras A, et al. J Am Coll Cardiol 2018;72:173-182.
High versus Low Blood-Pressure Target in Patients with Septic Shock.
Pierre Asfar et al. for the SEPSISPAM Investigators. N Engl J Med 2014; 370:1583-1593
Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
ALBANÈSE, J., LEONE, M., DELMAS, A. and MARTIN, C., 2005. Critical care medicine, 33(9), pp. 1897-1902
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial
ANNANE, D., VIGNON, P., RENAULT, A., BOLLAERT, P., CHARPENTIER, C., MARTIN, C., TROCHÉ, G., RICARD, J., NITENBERG, G., PAPAZIAN, L., AZOULAY, E. and BELLISSANT, E., 2007.
Lancet, 370(9588), pp. 676-684
Comparison of dopamine and norepinephrine in the treatment of shock.
DE BACKER, D., BISTON, P., DEVRIENDT, J., MADL, C., CHOCHRAD, D., ALDECOA, C., BRASSEUR, A., DEFRANCE, P., GOTTIGNIES, P. and VINCENT, J., 2010.
The New England journal of medicine, 362(9), pp. 779-789
Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis
DE BACKER, D., ALDECOA, C., NJIMI, H. and VINCENT, J., 2012. Critical care medicine, 40(3), pp. 725-730.
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock
A DELLINGER, R.P., et al 2012. Intensive care medicine, 39(2), pp. 165-228
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
MORELLI, A., ERTMER, C., REHBERG, S., LANGE, M., ORECCHIONI, A., CECCHINI, V., BACHETONI, A., D’ALESSANDRO, M., VAN AKEN, H., PIETROPAOLI, P. and WESTPHAL, M. 2009
Critical care (London, England), 13(4), pp. R130-R130
Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial
MORELLI, A., ERTMER, C., REHBERG, S., LANGE, M., ORECCHIONI, A., LADERCHI, A., BACHETONI, A., D’ALESSANDRO, M., VAN AKEN, H., PIETROPAOLI, P. and WESTPHAL, M. 2008.
Critical care (London, England), 12(6), pp. R143-R143
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials
OBA, Y. and LONE, N.A., 2014 Journal of critical care, 29(5), pp. 706-710
Efficacy and safety of dopamine versus norepinephrine in the management of septic shock
PATEL, G.P., GRAHE, J.S., SPERRY, M., SINGLA, S., ELPERN, E., LATEEF, O. and BALK, R.A. 2010. Shock (Augusta, Ga.), 33(4), pp. 375-380
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Circulation Part 9: post-cardiac arrest care
PEBERDY MA, CALLAWAY CW, Neumar, RW, et al. 2010.Circulation 2010;122(suppl 3):S768-S786
Vasopressin versus norepinephrine infusion in patients with septic shock
RUSSELL, J.A., WALLEY, K.R., SINGER, J., GORDON, A.C., HÉBERT, P.,C., COOPER, D.J., HOLMES, C.L., MEHTA, S., GRANTON, J.T., STORMS, M.M., COOK, D.J., PRESNEILL, J.J. and AYERS, D. 2008.
The New England journal of medicine, 358(9), pp. 877-887
Regional blood flow and oxygen transport in septic shock.
RUOKONEN, E., TAKALA, J., KARI, A., SAXÉN, H., MERTSOLA, J. and HANSEN, E.J. 1993. Critical care medicine, 21(9), pp. 1296-1303
Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock
SEGUIN, P., BELLISSANT, E., LE TULZO, Y., LAVIOLLE, B., LESSARD, Y., THOMAS, R. and MALLÉDANT, Y. 2002
Clinical pharmacology and therapeutics, 71(5), pp. 381-388
Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study
DÜNSER, M.,W., MAYR, A.J., ULMER, H., KNOTZER, H., SUMANN, G., PAJK, W., FRIESENECKER, B. and HASIBEDER, W.R., 2003
.Circulation, 107(18), pp. 2313-2319
“Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care”
FIELD JM, HAZINSKI MF, SAYRE MR, et al, Circulation, 2010, 122 (18 Suppl 3):640-56
Vasopressors for hypotensive shock. The Cochrane Database Of Systematic Reviews
HAVEL, C., ARRICH, J., LOSERT, H., GAMPER, G., MÜLLNER, M. and HERKNER, H. 2011. (5), pp. CD003709
Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial
LAUZIER, F., LÉVY, B., LAMARRE, P. and LESUR, O., 2006. Intensive care medicine, 32(11), pp. 1782-1789
Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock:
A prospective, randomized study
LEVY, B., BOLLAERT, P.E., CHARPENTIER, C., NACE, L., AUDIBERT, G., BAUER, P., NABET, P. and LARCAN, A., 1997.
Intensive care medicine, 23(3), pp. 282-287
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock.
A prospective, randomized pilot study
LEVY, B., PEREZ, P., PERNY, J., THIVILIER, C. and GERARD, A., 2011. Critical care medicine, 39(3), pp. 450-455
Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?
MARTIN, C., PAPAZIAN, L., PERRIN, G., SAUX, P. and GOUIN, F. 1993. Chest, 103(6), pp. 1826-1831
Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography
MATHUR, S.K., DHUNNA, R. and CHAKRABORTY, A. 2007 Indian Journal of Critical Care Medicine, 11(4), pp. 186-191
Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials
VASU, T.S., CAVALLAZZI, R., HIRANI, A., KAPLAN, G., LEIBY, B. and MARIK, P.E. 2012. Journal of intensive care medicine, 27(3), pp. 172-178
Safety of peripheral intravenous administration of vasoactive medication
Cardenas-Garcia J, Schaub KF, Belchikov YG, Narasimhan M, Koenig SJ, Mayo PH. J Hosp Med. 2015
Sep;10(9):581-5. doi: 10.1002/jhm.2394. Epub 2015 May 26. PubMed PMID: 26014852
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation
LEIER, C., Webel, J. & Bush, C.A. Circulation 1977, 56, pp.468–473
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock.
A prospective, randomized pilot study.
LEVY, B., PEREZ, P., PERNY, J., THIVILIER, C. and GERARD, A. 2011.
Critical care medicine, 39(3), pp. 450-455
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Y. and LONE, N.A., 2014. Journal of critical care, 29(5), pp. 706-710
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure:
A meta-regression analysis
THACKRAY, S., EASTHAUGH, J., FREEMANTLE, N. and CLELAND, J.G.F. 2002
European Journal Of Heart Failure, 4(4), pp. 515-529
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.
TACON, C.L., MCCAFFREY, J. and DELANEY, A. 2012.
Intensive care medicine, 38(3), pp. 359-367
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study
MORELLI, A., ERTMER, C., LANGE, M., DÜNSER, M., REHBERG, S., VAN AKEN, H., PIETROPAOLI, P. and WESTPHAL, M. 2008.
British journal of anaesthesia, 100(4), pp. 494-503
